Revista Científica Multidisciplinar Núcleo do Conhecimento,
Journal Year:
2023,
Volume and Issue:
unknown, P. 133 - 150
Published: Dec. 19, 2023
La
industria
de
semiconductores,
base
la
revolución
tecnológica
contemporánea,
ha
evolucionado
continuamente
desde
los
primeros
transistores
hasta
avanzados
microchips
hoy
en
día.
Históricamente
dominada
por
potencias
como
Estados
Unidos,
última
década
sido
testigo
del
ascenso
Asia,
especialmente
China,
un
centro
vital
producción
e
investigación,
reconfigurando
el
equilibrio
geopolítico
sector.
Impulsada
creciente
demanda
dispositivos
electrónicos
y
digitalización,
enfrenta
desafíos
reciente
escasez
chips,
agravada
pandemia
COVID-19.
Sin
embargo,
tecnologías
emergentes
puerta
túnel,
grafeno
memoria
resistiva
prometen
revolucionar
aún
más
campo.
Esta
revisión
narrativa
ofrece
análisis
integral
evolución
destacando
innovaciones
tecnológicas,
actuales
implicaciones
geopolíticas,
con
especial
atención
a
intersección
entre
economía
tecnología.
Advanced Drug Delivery Reviews,
Journal Year:
2025,
Volume and Issue:
218, P. 115524 - 115524
Published: Feb. 1, 2025
The
design
of
neural
tissue
models
with
architectural
and
biochemical
relevance
to
native
tissues
opens
the
way
for
fundamental
study
development
therapies
many
disorders
limited
treatment
options.
Here,
we
systematically
review
most
recent
literature
on
3D
bioprinted
models,
including
their
potential
use
in
drug
screening.
Neural
that
model
central
nervous
system
(CNS)
from
relevant
are
reviewed
comprehensive
summaries
each
study,
discussion
types,
bioinks
additives,
cell
types
used,
construct
shapes
culture
time,
characterization
methods
used.
In
this
review,
accentuate
lack
standardization
among
analyze
functionality
(including
chemical,
metabolic
other
pathways)
mechanical
constructs,
discuss
as
a
critical
area
future
exploration.
These
gaps
must
be
addressed
technology
applied
effective
screening
applications,
despite
its
enormous
rapid
efficient
biomimetic,
printed
is
promising
evaluation
vivo
multiple
levels
should
sought
adequately
compare
performance
develop
viable
options
neurodegenerative
diseases,
or
conditions
affect
CNS.
Biosensors,
Journal Year:
2024,
Volume and Issue:
14(2), P. 86 - 86
Published: Feb. 4, 2024
The
convergence
of
microfluidics
and
organ-on-a-chip
(OoC)
technologies
has
revolutionized
our
ability
to
create
advanced
in
vitro
models
that
recapitulate
complex
physiological
processes
[...]
Molecules,
Journal Year:
2025,
Volume and Issue:
30(5), P. 1017 - 1017
Published: Feb. 22, 2025
Neurodegenerative
disorders
present
significant
therapeutic
challenges,
particularly
due
to
the
complex
nature
of
drug
delivery
central
nervous
system.
This
review
investigates
applications
various
biopolymers
in
neuroprotection
and
their
potential
role
treating
neurodegeneration.
We
a
critical
analysis
natural
synthetic
biopolymers,
focusing
primarily
on
chitosan,
fish
collagen/gelatin,
alginate
as
key
agents.
The
examines
fundamental
mechanisms
brain
development
neurodegeneration,
establishing
framework
for
understanding
how
these
interact
with
neural
tissues.
By
analyzing
recent
experimental
studies,
we
evaluate
effectiveness
different
biopolymer-based
systems
crossing
blood-brain
barrier
subsequent
neuroprotective
effects.
Additionally,
promising
materials,
including
lignin,
poly
lactic-co-glycolic
acid,
glucose-modified
bovine
serum
albumin/procyanidin
complexes,
are
briefly
explored
provide
comprehensive
overview
current
developments
field.
Our
reveals
that
approaches
offer
unique
advantages
both
delivery,
potentially
opening
new
avenues
neurodegenerative
conditions.
synthesizes
knowledge
identifies
directions
future
research
strategies.
Tissue Engineering Part B Reviews,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 21, 2025
The
study
of
the
human
nervous
system
remains
challenging
due
to
its
inherent
complexity
and
difficulty
in
obtaining
original
samples.
Three-dimensional
(3D)
bioprinting
is
a
rapidly
evolving
technology
field
tissue
engineering
that
has
made
significant
contributions
several
disciplines,
including
neuroscience.
In
order
more
accurately
reflect
intricate
multicellular
milieu
vivo
environment,
an
increasing
number
studies
have
commenced
experimentation
with
coprinting
diverse
cell
types.
This
article
provides
overview
technical
details
application
3D
multiple
types
neuroscience,
focusing
on
challenges
research
conducted
based
printing.
review
discusses
interactions
systems,
stem
applications,
construction
brain-like
organoids,
establishment
disease
models,
potential
for
integrating
other
culture
techniques.
Ibrain,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 22, 2025
Abstract
Neurodegenerative
diseases
(NDs)
are
disorders
that
drastically
alter
the
physiological
functioning
of
neurons
in
brain.
These
processes
often
accompanied
by
abnormal
protein
aggregates
physical
and
chemical
properties
brain
tissue
peripheral
nerves.
The
causes
NDs
complex,
involving
genetic
factors,
neuroinflammation,
oxidative
stress,
environmental
influences,
lifestyle,
while
symptoms
progression
vary
significantly
based
on
mechanisms
cell
death.
Currently,
no
definitive
treatment
exists
for
NDs,
as
underlying
degenerative
remain
poorly
understood.
Existing
therapies
focus
symptom
alleviation
but
insufficient
to
halt
or
prevent
disease
progression.
This
highlights
urgent
need
strategies
mimic
pathophysiology
facilitating
deeper
insights
development
effective
treatments.
Conventional
vitro
vivo
models
attempt
replicate
fail
capture
complexity
nervous
its
interactions.
In
this
context,
3D
microfluidic
bioprinting
emerges
a
transformative
technology.
By
enabling
precise
deposition
cells
biomaterials,
it
allows
creation
with
high
degree
structural
functional
complexity.
advancements
provide
valuable
platform
faithfully
modeling
bridging
critical
gaps
our
understanding,
paving
way
toward
innovative
therapeutic
approaches.
ChemBioChem,
Journal Year:
2024,
Volume and Issue:
25(23)
Published: Aug. 26, 2024
Abstract
Organ‐On‐a‐Chip
(OOC)
is
a
multichannel
3D‐microfluidic
cell‐culture
system
incorporated
in
chip
that
simulates
the
behavior
of
an
organ.
This
technology
relies
on
multidisciplinary
science
benefits
from
and
contributes
progress
many
fields
including
microbiology,
microfluidics,
biomaterials,
bioengineering.
review
article
summarizes
achievements
various
organ‐on‐chip
technologies.
It
highlights
significant
advantages
this
terms
reducing
animal
testing
providing
personalized
medical
responses.
In
addition,
paper
demonstrates
how
OOC
becoming
promising
powerful
tool
pharmaceutical
research
to
combat
diseases.
predicts
not
only
effects
drugs
target
organs
but
also,
using
body‐on‐a‐chip
systems,
it
may
provide
insights
into
side
drug
delivery
other
organs.
Likewise,
models
used
for
construction
organ‐on‐a‐chip
devices
are
investigated
along
with
design
materials
microfluidic
devices.
For
each
OOC,
integrated
monitoring
within
chips
(e.
g.,
sensors
biosensors)
discussed.
We
also
discuss
evolution
FDA
regulations
potential
near
future
integrating
OOCs
protocols
support
reduce
need
failure
rates
preclinical
clinical
studies.
Journal of Neuroscience Methods,
Journal Year:
2023,
Volume and Issue:
399, P. 109979 - 109979
Published: Sept. 30, 2023
Organotypic
brain
slices
are
three-dimensional
150
µm–thick
sections
of
a
postnatal
day
10
mouse
and
can
be
cultured
for
several
weeks
in
vitro.
In
such
the
complex
cellular
connections
preserved
with
high
viability.
These
connected
to
collagen-loaded
microcontact
prints
develop
simple
brain-on-a-chip
model.
Using
printing
technique,
many
peptides
or
proteins
printed
onto
semipermeable
membrane
linked
slices.
On
these
prints,
brain-derived
nerve
fibers
grow
out,
microglia
get
activated
migrate
also
new
vessels
formed.
Such
model
may
allow
drugs
diagnostic
method
neurodegenerative
diseases.
Annals of Medicine and Surgery,
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 16, 2024
Introduction:
Approximately
50
million
people
worldwide
have
epilepsy,
with
many
not
achieving
seizure
freedom.
Organ-on-chip
technology,
which
mimics
organ-level
physiology,
could
revolutionize
drug
development
for
epilepsy
by
replacing
animal
models
in
preclinical
studies.
Our
goal
is
to
determine
if
customized
micro-physiological
systems
can
lead
tailored
treatments
epileptic
patients.
Materials
and
methods:
A
comprehensive
literature
search
was
conducted
utilizing
various
databases,
including
PubMed,
Ebscohost,
Medline,
the
National
Library
of
Medicine,
using
a
predetermined
strategy.
We
focused
on
articles
that
addressed
role
personalized
individual
responses
discussed
different
types
diagnosis,
current
treatment
options.
Additionally,
explored
components
design
considerations
were
reviewed
identify
challenges
opportunities
challenging
cases.
Results:
The
system
offers
more
accurate
cost-effective
alternative
traditional
assessing
effects,
toxicities,
disease
mechanisms.
Nevertheless,
designing
patient-specific
presents
critical
considerations,
integration
analytical
biosensors
patient-derived
cells,
while
addressing
regulatory,
material,
biological
complexities.
Material
selection,
standardization,
vascular
systems,
cost
efficiency,
real-time
monitoring,
ethical
are
also
crucial
successful
use
this
technology
development.
Conclusion:
future
organ-on-chip
holds
great
promise,
potential
integrate
artificial
intelligence
machine
learning
Organs-on-a-Chip,
Journal Year:
2023,
Volume and Issue:
5, P. 100033 - 100033
Published: Dec. 1, 2023
With
the
approval
of
Food
and
Drug
(FDA)
Modernization
Act
2.0,
pharmaceutical
industry
is
poised
to
expand
its
research
components
with
a
plethora
alternative
models,
including
organ-on-microfluidic
chips
in
pharma
biotechnology,
resulting
personalized
approach.
Microfluidics
opens
new
possibilities
for
study
cell
biology,
especially
better
understanding
cell-cell
interactions
pathophysiology
neurodegenerative
diseases
vitro,
use
these
models
assess
efficacy
novel
therapies
promising.
These
thumb-sized
organ-on-a-chip
systems
have
potential
reduce
animal
testing
replace
simple
2D
culture
that
do
not
succeed
resemble
complex
physiology
tissues
organs.
Restoring
critical
aspects
endothelial-brain
immune
communication
biomimetic
system
using
microfluidics
may
accelerate
process
central
nervous
(CNS)
drug
discovery
improve
our
mechanisms
multiple
diseases.
In
addition,
organ-on-chip
technologies
can
be
used
optimize
targets
toxicity
real-time,
which
significantly
help
minimize
requirements,
as
authorized
by
recent
FDA
Act.
This
Review
initially
summarizes
fundamental
advantages
microfluidic
creating
compartmentalized
three-dimensional
architectures
neural
tissue
cells
such
neurons,
glial
cells,
endothelial
their
ability
recapitulate
spatiotemporal
biophysicochemical
gradients
mechanical
microenvironments.
Then,
brain
cell-astroglia-on-a-chip
focus
on
Alzheimer's
disease,
Parkinson's
Huntington's
disease
amyotrophic
lateral
sclerosis
are
introduced.
Finally,
current
limitations
devices
strategies
overcome
them
discussed.
Revista Científica Multidisciplinar Núcleo do Conhecimento,
Journal Year:
2023,
Volume and Issue:
unknown, P. 133 - 150
Published: Dec. 19, 2023
Semiconductor
Industry,
the
Foundation
of
Contemporary
Technological
Revolution,
has
been
continuously
evolving
from
early
transistors
to
today’s
advanced
microchips.
Historically
dominated
by
powers
such
as
United
States,
last
decade
witnessed
rise
Asia,
especially
China,
a
vital
center
for
production
and
research,
reshaping
geopolitical
balance
sector.
Driven
growing
demand
electronic
devices
digitization,
industry
faces
challenges
recent
chip
shortage,
exacerbated
COVID-19
pandemic.
However,
emerging
technologies
like
tunnel
gate
transistors,
graphene,
resistive
memory
promise
further
revolutionize
field.
This
narrative
review
provides
comprehensive
analysis
evolution
semiconductors,
highlighting
technological
innovations,
current
challenges,
implications,
with
special
focus
on
intersection
between
economy
technology.